Clinical trial / 2007
Folic acid supplementation (800 µg/day for 3 years) slowed age-related low-frequency hearing decline in older Dutch adults.
A double-blind trial in the Netherlands randomized 728 older adults with elevated homocysteine to daily oral folic acid (800 microg) or placebo for 3 years. After 3 years, low-frequency hearing thresholds increased by 1.0 dB (95% CI, 0.6 to 1.4 dB) in the folic acid group versus 1.7 dB (CI, 1.3 to 2.1 dB) in the placebo group (difference, -0.7 dB [CI, -1.2 to -0.1 dB]; P = 0.020). Folic acid supplementation did not affect the decline in high-frequency hearing. Limitations include strict homocysteine eligibility criteria and the study taking place in a setting without food folic acid fortification, where baseline folate levels were about half those of the U.S. population.
- Study type
- Double-blind randomized placebo-controlled trial
- Who was studied
- 728 older Dutch men and women with elevated homocysteine (>=13 micromol/L) and normal vitamin B12 (>=200 pmol/L)
- What was measured
- 3-year change in low-frequency and high-frequency hearing thresholds
THE PAPER
Effects of folic acid supplementation on hearing in older adults: a randomized, controlled trial.
Durga J, Verhoef P, Anteunis LJ, Schouten E, Kok FJ. Ann Intern Med, 2007.
PubMed 17200216 ↗DOI 10.7326/0003-4819-146-1-200701020-00003 ↗
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.